Cardiovascular proteomics is a specialized field within the broader domain of proteomics, dedicated to the in-depth investigation of proteins related to cardiovascular health and disease. This scientific discipline employs advanced techniques to comprehensively analyze the intricate protein landscape of the cardiovascular system. By delving into the complexities of protein expression, post-translational modifications, and interactions, researchers in cardiovascular proteomics strive to uncover vital insights into the molecular mechanisms underlying various cardiovascular conditions. This nuanced approach not only enhances our understanding of heart-related diseases but also opens new avenues for identifying potential biomarkers, unraveling disease progression pathways, and pinpointing therapeutic targets. The integration of cutting-edge technologies, such as high-throughput mass spectrometry, empowers scientists to systematically explore the intricate interplay of proteins, contributing to the ongoing pursuit of innovative diagnostic methods and targeted therapeutic interventions in the dynamic field of cardiovascular health.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom